Previous 10 | Next 10 |
2023-09-21 14:37:34 ET More on uniQure Seeking Alpha’s Quant Rating on uniQure Historical earnings data for uniQure Financial information for uniQure uniQure: AMT-130 Data And Other Catalysts In H2 2023 uniQure: The AMT-130 Readout For ...
2023-09-07 06:50:56 ET Summary uniQure has made progress in advancing its gene therapy candidates, including AMT-130 for Huntington's disease; additional data from phase I/II study expected Q4 of 2023. Interim data from the phase I/II study of AMT-130 showed it was safe and tolera...
2023-09-05 13:10:58 ET Shares of uniQure (NASDAQ: QURE) were down more than 11% as of 1:06 p.m. on Tuesday after the gene-therapy company announced that the Food and Drug Administration (FDA) had cleared its investigational new drug (IND) application for AMT-260, a treatment for...
2023-09-05 10:38:09 ET More on uniQure Seeking Alpha’s Quant Rating on uniQure Historical earnings data for uniQure Financial information for uniQure uniQure: The AMT-130 Readout Biggest stock movers today: Patterson Companies, Peloton Interact...
2023-09-05 10:11:48 ET More on Airbnb Seeking Alpha’s Quant Rating on Airbnb Historical earnings data for Airbnb Financial information for Airbnb Airbnb: S&P 500 Addition Strengthens Its Robust Growth Story Airbnb: Upgrading To Hold, Headwi...
2023-09-05 10:00:14 ET More on Health Care Select Sector SPDR Seeking Alpha’s Quant Rating on Health Care Select Sector SPDR Dividend scorecard for Health Care Select Sector SPDR Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare ( XLV ) ...
LEXINGTON, Mass. and AMSTERDAM, Sept. 05, 2023 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Investigat...
Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 Blackstone and Airbnb Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 PR Newswire NEW YORK , Se...
2023-09-01 18:33:42 ET More on Airbnb and Blackstone Airbnb: Upgrading To Hold, Headwinds Priced In How To Think About Airbnb Blackstone: Load Up Before It Recovers Its All-Time Highs (Rating Upgrade) Blackstone: Time For A Rating Downgrade Airbnb: Ev...
2023-08-01 08:01:18 ET uniQure press release ( NASDAQ: QURE ): Q2 EPS of -$1.44 may not be comparable to consensus of $2.72. Revenue of $2.4M (+380.0% Y/Y). Revenue for the three months ended June 30, 2023 was $2.4 million, compared to $0.5 million in the same period i...
News, Short Squeeze, Breakout and More Instantly...
uniQure N.V. Company Name:
QURE Stock Symbol:
NASDAQ Market:
Genezen to Acquire uniQure's Commercial Gene Therapy Manufacturing Operations in Lexington, MA PR Newswire Strategic acquisition will enable Genezen to deliver late-phase and commercial gene therapy development and manufacturing services to customers around the world. ...
~ Proposed divestiture streamlines uniQure’s focus and represents an important milestone in its ongoing effort to significantly reduce operating expenses ~ ~ Genezen to manufacture global commercial supply of HEMGENIX ® and support uniQure’s pipeline progr...
~ Designation based on 24-month interim Phase I/II clinical data for AMT-130 announced in December 2023 ~ ~ AMT-130 is the first therapeutic candidate to receive RMAT Designation for Huntington’s disease ~ ~ Receiving RMAT designation enables increased collaboration with ...